AlphaYouNB
Insider selling
Namandje Bumpus sold $13K of Recursion Pharmaceuticals, Inc. (RXRX) stock
Namandje Bumpus, Dir of Recursion Pharmaceuticals, Inc. (RXRX), sold 3,963 shares of RXRX stock worth $13K, per an SEC Form 4 filed Jun 22, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 17, 2026, 5 days before it was made public.
RXRX has moved +30.2% since the trade date, from $3.11 to $4.05 (Sep 22, 2026 close).
- Traded
- Jun 17, 2026
- Disclosed
- Jun 22, 2026
- Filing delay
- 5 days
- Price since
- +30.2%
- Role
- Dir
- Source
- SEC Form 4
More RXRX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.